Hans Hull - 26 Jan 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Business Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
26 Jan 2022
Transactions value $
$0
Form type
4
Filing time
02 Feb 2022, 19:14:26
Previous filing
28 May 2021
Next filing
21 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Award $0 +113K $0.00 113K 26 Jan 2022 Common Stock 113K $11.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.